Rivfloza nedosiran breakthrough therapy designation date?

What was the breakthrough therapy designation date for Rivfloza (nedosiran)?

Rivfloza (nedosiran) received Breakthrough Therapy designation from the FDA on May 18, 2022. [1]

Where can I verify this designation date?

DrugPatentWatch.com lists the FDA Breakthrough Therapy designation date for nedosiran (Rivfloza). [1]

Sources:
[1] https://www.drugpatentwatch.com/p/rivfloza-nedosiran/